Company Filing History:
Years Active: 1993-2006
Title: Innovations of Gilbert M Iverson
Introduction
Gilbert M Iverson is a notable inventor based in Del Mar, California. He has made significant contributions to the field of immunology, holding three patents that focus on innovative therapeutic and diagnostic methods. His work has the potential to impact the treatment of various antibody-mediated pathologies.
Latest Patents
Iverson's latest patents include a composition for inducing humoral anergy to an immunogen. This composition comprises a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule. The conjugates he developed are useful for treating antibody-mediated pathologies caused by foreign or self-immunogens. Another significant patent involves domain 1 β2GPI polypeptides and methods of using them. These polypeptides are designed to detect β2GPI-dependent antiphospholipid antibodies, which are associated with conditions such as thrombosis and fetal loss. His inventions provide methods for inducing tolerance using these polypeptides.
Career Highlights
Iverson is currently associated with La Jolla Pharmaceutical Company, where he continues to advance his research and innovations. His work is characterized by a strong focus on therapeutic applications that address critical health issues.
Collaborations
Some of his notable coworkers include Paul A Barstad and David Matthew Marquis. Their collaborative efforts contribute to the innovative research environment at La Jolla Pharmaceutical Company.
Conclusion
Gilbert M Iverson's contributions to immunology through his patents and research are noteworthy. His work not only enhances our understanding of antibody-mediated pathologies but also paves the way for new therapeutic approaches.